Leveraging the tolerogenic potential of TNF-α and regulatory B cells in organ transplantation
Open Access
- 27 April 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14
Abstract
A subset of B-cells with tolerogenic functions, termed B-regulatory cells or Bregs, is characterized by the expression of anti-inflammatory/tolerogenic cytokines, namely IL-10, TGF-β, and IL-35, that contribute to their regulatory functions. Breg regulation favors graft acceptance within a tolerogenic milieu. As organ transplantation invariably triggers inflammation, new insights into the crosstalk between cytokines with dual properties and the inflamed milieu are needed to tailor their function toward tolerance. Using TNF-α as a proxy of dual-function cytokines involved in immune-related diseases and transplantation settings, the current review highlights the multifaceted role of TNF-α. It focuses on therapeutic approaches that have revealed the complexity of TNF-α properties tested in clinical settings where total TNF-α inhibition has proven ineffective and often detrimental to clinical outcomes. To improve the efficacy of current TNF-α inhibiting therapeutics, we propose a three-prong strategy to upregulate the tolerogenic pathway engaging the TNFR2 receptor while simultaneously inhibiting the inflammatory mechanisms associated with TNFR1 engagement. When combined with additional administrations of Bregs-TLR that activate Tregs, this approach may become a potential therapeutic in overcoming transplant rejection and promoting graft tolerance.Keywords
Funding Information
- National Institutes of Health
This publication has 55 references indexed in Scilit:
- TNF-α impairs differentiation and function of TGF-β-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathwayJournal of Molecular Cell Biology, 2012
- TGF-β in transplantation toleranceCurrent Opinion in Immunology, 2011
- Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?Annals of Neurology, 2010
- Transmembrane TNF- : structure, function and interaction with anti-TNF agentsRheumatology, 2010
- Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survivalBlood, 2008
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt functionNature, 2008
- The inhibitory cytokine IL-35 contributes to regulatory T-cell functionNature, 2007
- Role of tumor necrosis factor-α in graft-versus-host disease and graft-versus-leukemia responsesTransplantation and Cellular Therapy, 2003
- Prevention of Arthritis by Interleukin 10–producing B CellsJournal of Experimental Medicine, 2003
- B cells regulate autoimmunity by provision of IL-10Nature Immunology, 2002